Effectiveness and Safety of Yiqitongluo Granule for Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2197 participants.
Also called NCT02604654
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 2,197 participants
- Sponsor
- Registry
-
NCT02604654
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT02604654. Allocation not applicable; no masking; primary purpose treatment. Start 2015-12-29 (actual); primary completion 2017-11-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effectiveness and Safety of Yiqitongluo Granule for Stroke
- Condition
- Stroke
- Intervention (Drug)
- Yiqitongluo granule
- Lead sponsor
- Yi Yang
- Collaborator
- Shineway Pharmaceutical Co.,Ltd
Record details
- Record id
cardio:ct-nct02604654- Content hash
b58168e3233a5bc5a820bf2ca4b22f7aae3603e625c1ac84434ef9952b44f29c